US listings, nothing else

Tiers: three levels, three company profiles

Nasdaq operates three tiers, moving from large seasoned issuers to mid-cap growth companies to smaller issuers. NYSE is also tiered, positioned more toward established large caps. A tier is not permanent — you can move up when you qualify, and you will be required to remedy or face a lower tier if you fall below continued-listing standards. So the choice is not "the best tier", it is the one you can hold after listing. Specific financial and liquidity thresholds follow the exchange's current rules and are revised from time to time; we do not copy numbers onto this site, and we check each item against the latest standard when advising.

Investor composition: whether anyone trades you after listing

Technology and biotech issuers find deeper analyst coverage and institutional pools on Nasdaq. Traditional industries, financials and large industrials carry a higher share of long-only capital on NYSE. This often matters more to valuation than fee differences — no coverage means no liquidity, and no liquidity means a discount at the next raise.

Review focus: same substance, different questioning

Both exchanges press on the same things: is the cap table clean, are related-party dealings at arm's length, is management stable, are use-of-proceeds stated concretely, is there material dependence on a single customer or supplier. The difference is style and pace, not the standard. Any claim that one exchange is "easier to pass" deserves a request for evidence.

When a traditional IPO does not work

• Financials for the latest year cannot be restated under US GAAP, or historical workpapers are missing;
• Nominee holdings, employee holding platforms or the offshore structure are not yet cleaned up;
• The raise is too small and fixed costs dominate — under the 2026 rules this is fatal;
• The business depends on one customer or one supplier with no credible explanation of durability.

When a reverse merger does not work

• No clean shell: undisclosed liabilities, litigation, or a poor SEC record;
• Uplisting conditions cannot be met for a prolonged period, leaving you on OTC;
• You expect the reverse merger itself to raise substantial new money — it usually does not.

When a SPAC does not work

• Target valuation is far out of line with the trust size, requiring an excessive PIPE;
• The dilution from sponsor promote and redemptions is unaffordable;
• Markets deteriorate inside the merger window and redemptions leave too little cash at closing.

When a direct listing does not work

• You need to raise primary capital — a direct listing issues no new shares;
• There is no existing shareholder base or liquidity to support an opening price;
• Under the 2026 rules the direct-listing route is confined to the higher tier, which excludes most small and mid-cap issuers.

The four routes are not ranked by sophistication. For many companies the right path is a reverse merger to obtain a ticker, one to two years of real work on financials and controls, then an uplisting — slow, but controllable. Forcing a reverse merger when you actually qualify for an IPO trades long-term valuation for short-term speed.

One: adviser networks are specific, not abstract

Banking runs on specific people: which audit partner at which firm, which capital markets group at which law firm, which bookrunner on which syndicate. Our network sits on the US line — PCAOB-registered firms, US securities counsel, underwriters currently reviewing with Nasdaq and NYSE. Hong Kong and A-share work is a different set of people. Switching markets means building a network from zero, and that is measured in years.

Two: rule systems differ; experience does not transfer

The US model is disclosure-driven with SEC comment. Hong Kong leans on sponsor responsibility and compliance with listing rules. A-shares run a review-and-registration regime heavily shaped by domestic regulatory cycles. Each judges "what kind of company can list" differently, and a document package built for the US largely cannot be reused. Teams claiming all three markets are usually shallow in all three.

Three: the people are not fungible

A US-listed CFO must handle SOX 404, 20-F / 10-K disclosure and English-language roadshow Q&A. Hong Kong emphasises work with sponsors and the onshore business. The A-share board secretary system is another discipline entirely. Put the same candidate into the wrong market and a strong CV solves nothing. We stock one line of people.

Four: focus is a deliverable form of certainty

Doing only US listings means every case, every adviser relationship and every failure lesson sits inside one rule set. What a client gets is not "we also do this", but "we have seen this many times and know where it usually dies". That is what we trade market size for.